Комбинированная терапия гастроэзофагеальной рефлюксной болезни при коморбидности с функциональной диспепсией

Каримов М.М., Зуфаров П.С., Собирова Г.Н., Каримова Д.К., Хайруллаева С.С.

dc.contributor.author	Каримов М.М., Зуфаров П.С., Собирова Г.Н., Каримова Д.К., Хайруллаева С.С.
dc.date.accessioned	2023-09-17T10:24:14Z
dc.date.available	2023-09-17T10:24:14Z
dc.date.issued	2023
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/8960
dc.description.abstract	It has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more eff ective regression of symptoms of impaired motility of the esophagus and stomach	en_US
dc.language.iso	other	en_US
dc.publisher	Эксперементальная и клиническая гастроэнтерология №211(3). 2023.С. 42-45	en_US
dc.relation.ispartofseries	№211(3). 2023;DOI: 10.31146/1682-8658-ecg-211-3-41-45
dc.subject	gastroesophageal refl ux disease, functional dyspepsia, proton pump inhibitors, prokinetics	en_US
dc.title	Комбинированная терапия гастроэзофагеальной рефлюксной болезни при коморбидности с функциональной диспепсией	en_US
dc.type	Article	en_US